1. Lactacystin Exhibits Potent Anti-tumor Activity in an Animal Model of Malignant Glioma when Administered via Controlled-release Polymers

   • Federico G. Legnani
   • Gustavo Pradilla
   • Alessandro Olivi

   Laboratory Investigation 11 April 2006 Pages: 225 - 232

2. Destruction of human retinoblastoma after treatment by the E variant of encephalomyocarditis virus

   • Masazumi Adachi
   • Steven E. Brooks
   • Francis A. Caccavo

   Laboratory Investigation 10 March 2006 Pages: 233 - 240

3. Resident training in neurosurgical oncology: results of the survey of North American training programs by the AANS/CNS Section on Tumors

   • Randy Jensen
   • Donald O'Rourke
   • Raymond Sawaya

   Laboratory Investigation 17 March 2006 Pages: 241 - 246

4. Synthetic Smac peptide enhances the effect of etoposide-induced apoptosis in human glioblastoma cell lines

   • Katsu Mizukawa
   • Atsufumi Kawamura
   • Eiji Kohmura

   Laboratory Investigation 31 March 2006 Pages: 247 - 255

5. Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13

   • Edward Rustamzadeh
   • Daniel A. Vallera
   • Walter A. Hall

   Laboratory Investigation 29 November 2005 Pages: 257 - 266

6. Pathological laughter and behavioural change in childhood pontine glioma

   • Darren R. Hargrave
   • Donald J. Mabbott
   • Eric Bouffet

   Clinical-patient studies 29 November 2005 Pages: 267 - 271

7. Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas

   • Muhamad Thohar Arifin
   • Seiji Hama
   • Kaoru Kurisu

   Clinical--patient studies 14 April 2006 Pages: 273 - 277

8. Osmotic blood–brain barrier disruption chemotherapy for diffuse pontine gliomas

   • Walter A. Hall
   • Nancy D. Doolittle
   • Edward A. Neuwelt

   Clinical-patient studies 29 November 2005 Pages: 279 - 284

9. Brain metastases from apocrine carcinoma of the scalp: case report

   • Shinji Shimato
   • Toshihiko Wakabayashi
   • Jun Yoshida

   Clinical-patient studies 29 November 2005 Pages: 285 - 289

10. Long-term relapse-free survival with supratentorial primitive neuroectodermal tumor in an adult: a case report

    • Thomas Krampulz
    • Volkmar H. Hans
    • Maximilian J.A. Puchner

    Clinical-patient studies 10 March 2006 Pages: 291 - 294

11. Tumor growth, invasion, and angiogenesis in malignant gliomas

    • Eric T. Wong

    Clinial Study 29 November 2005 Pages: 295 - 296

12. 3-Tesla intraoperative MR imaging for neurosurgery

    • Walter A. Hall
    • Walter Galicich
    • Charles L. Truwit

    Clinical-patient studies 29 November 2005 Pages: 297 - 303

13. Treatment recommendations for the various subgroups of neurocytomas

    • Dirk Rades
    • Steven E. Schild

    Clinical Study 31 March 2006 Pages: 305 - 309

14. Dose–response relationship for fractionated irradiation in the treatment of spinal meningeal melanocytomas: a review of the literature

    • Dirk Rades
    • Steven E. Schild

    Clinical-patient studies 03 December 2005 Pages: 311 - 314

15. Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients

    • Nicole E. Marshall
    • Karla V. Ballman
    • Jan C. Buckner

    Clinical–patient studies 05 November 2005 Pages: 315 - 320

16. Postoperative radiotherapy in cranial ganglioglioma

    • Faruk Zorlu
    • Ugur Selek
    • Murat Gurkaynak

    Clinical--patient studies 29 November 2005 Pages: 321 - 324

17. Postoperative cerebral abscess formation caused by Toxocara canis in a meningioma cavity

    • Askin Gorgulu
    • Baki S. Albayrak
    • Omer Tural

    Letter to Editor 29 November 2005 Pages: 325 - 326